The Pan-therapeutic Resistance of Disseminated Tumor Cells: Role of Phenotypic Plasticity and the Metastatic Microenvironment

Overview

Journal Semin Cancer Biol

Specialty Oncology

Date 2019 Aug 4

PMID 31376430

Citations 24

Authors

Bo Ma

Alan Wells

Amanda M Clark

Affiliations

Soon will be listed here.

Abstract

Cancer metastasis is the leading cause of mortality in patients with solid tumors. The majority of these deaths are associated with metastatic disease that occurs after a period of clinical remission, anywhere from months to decades following removal of the primary mass. This dormancy is prominent in cancers of the breast and prostate among others, leaving the survivors uncertain about their longer-term prognosis. The most daunting aspect of this dormancy and re-emergence is that the micrometastases in particular, and even large lethal outgrowths are often show resistance to agents to which they have not been exposed. This suggests that in addition to specific mutations that target single agents, there also exist adaptive mechanisms that provide this pan-resistance. Potential molecular underpinnings of which are the topic of this review.

Citing Articles

Liver Metastasis in Cancer: Molecular Mechanisms and Management.

Xu W, Xu J, Liu J, Wang N, Zhou L, Guo J MedComm (2020). 2025; 6(3):e70119.

PMID: 40027151 PMC: 11868442. DOI: 10.1002/mco2.70119.

Statins as Secondary Preventive Agent to Limit Breast Cancer Metastatic Outgrowth.

Atale N, Wells A Int J Mol Sci. 2025; 26(3).

PMID: 39941069 PMC: 11818786. DOI: 10.3390/ijms26031300.

Mediator kinase inhibitors suppress triple-negative breast cancer growth and extend tumor suppression by mTOR and AKT inhibitors.

Ding X, Liang J, Sharko A, Hilimire T, Li J, Loskutov J Proc Natl Acad Sci U S A. 2024; 121(47):e2414501121.

PMID: 39541354 PMC: 11588072. DOI: 10.1073/pnas.2414501121.

Review on effects and mechanisms of plant-derived natural products against breast cancer bone metastasis.

Zhang X, Miao J, Song Y, Zhang J, Miao M Heliyon. 2024; 10(18):e37894.

PMID: 39318810 PMC: 11420494. DOI: 10.1016/j.heliyon.2024.e37894.

[Advances of Fundamental Research on Traditional Chinese Medicine in Regulation of Tumor-associated Macrophages for the Prevention and Treatment of  Lung Cancer Metastasis].

Liu S, Li J, Que Z, Yu P, Tian J Zhongguo Fei Ai Za Zhi. 2024; 27(7):541-549.

PMID: 39147709 PMC: 11331253. DOI: 10.3779/j.issn.1009-3419.2024.106.14.

References

Gonzalez-Angulo A, Morales-Vasquez F, Hortobagyi G . Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol. 2007; 608:1-22. DOI: 10.1007/978-0-387-74039-3_1. View

Burnier J, Wang N, Michel R, Hassanain M, Li S, Lu Y . Type IV collagen-initiated signals provide survival and growth cues required for liver metastasis. Oncogene. 2011; 30(35):3766-83. DOI: 10.1038/onc.2011.89. View

Sharma P, Hu-Lieskovan S, Wargo J, Ribas A . Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy. Cell. 2017; 168(4):707-723. PMC: 5391692. DOI: 10.1016/j.cell.2017.01.017. View

Ikeguchi M, Makino M, Kaibara N . Clinical significance of E-cadherin-catenin complex expression in metastatic foci of colorectal carcinoma. J Surg Oncol. 2001; 77(3):201-7. DOI: 10.1002/jso.1095. View

Strauss R, Li Z, Liu Y, Beyer I, Persson J, Sova P . Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity. PLoS One. 2011; 6(1):e16186. PMC: 3021543. DOI: 10.1371/journal.pone.0016186. View

Gao H, Chakraborty G, Lee-Lim A, Mo Q, Decker M, Vonica A . The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites. Cell. 2012; 150(4):764-79. PMC: 3711709. DOI: 10.1016/j.cell.2012.06.035. View

Kobayashi A, Okuda H, Xing F, Pandey P, Watabe M, Hirota S . Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone. J Exp Med. 2011; 208(13):2641-55. PMC: 3244043. DOI: 10.1084/jem.20110840. View

Steele C, Karim S, Leach J, Bailey P, Upstill-Goddard R, Rishi L . CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma. Cancer Cell. 2016; 29(6):832-845. PMC: 4912354. DOI: 10.1016/j.ccell.2016.04.014. View

Thomas P, Hayashi H, Zimmer R, Forse R . Regulation of cytokine production in carcinoembryonic antigen stimulated Kupffer cells by beta-2 adrenergic receptors: implications for hepatic metastasis. Cancer Lett. 2004; 209(2):251-7. DOI: 10.1016/j.canlet.2003.12.027. View

10.

Janni W, Vogl F, Wiedswang G, Synnestvedt M, Fehm T, Juckstock J . Persistence of disseminated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse--a European pooled analysis. Clin Cancer Res. 2011; 17(9):2967-76. DOI: 10.1158/1078-0432.CCR-10-2515. View

11.

Sosa M, Avivar-Valderas A, Bragado P, Wen H, Aguirre-Ghiso J . ERK1/2 and p38α/β signaling in tumor cell quiescence: opportunities to control dormant residual disease. Clin Cancer Res. 2011; 17(18):5850-7. PMC: 3226348. DOI: 10.1158/1078-0432.CCR-10-2574. View

12.

Hanker A, Estrada M, Bianchini G, Moore P, Zhao J, Cheng F . Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2 Breast Cancer. Cancer Res. 2017; 77(12):3280-3292. PMC: 5482178. DOI: 10.1158/0008-5472.CAN-16-2808. View

13.

Gilbert L, Hemann M . DNA damage-mediated induction of a chemoresistant niche. Cell. 2010; 143(3):355-66. PMC: 2972353. DOI: 10.1016/j.cell.2010.09.043. View

14.

Kienast Y, von Baumgarten L, Fuhrmann M, Klinkert W, Goldbrunner R, Herms J . Real-time imaging reveals the single steps of brain metastasis formation. Nat Med. 2009; 16(1):116-22. DOI: 10.1038/nm.2072. View

15.

MacGrogan D, Bookstein R . Tumour suppressor genes in prostate cancer. Semin Cancer Biol. 1997; 8(1):11-9. DOI: 10.1006/scbi.1997.0048. View

16.

Sangaletti S, Tripodo C, Sandri S, Torselli I, Vitali C, Ratti C . Osteopontin shapes immunosuppression in the metastatic niche. Cancer Res. 2014; 74(17):4706-19. DOI: 10.1158/0008-5472.CAN-13-3334. View

17.

Motzer R, Escudier B, Mcdermott D, George S, Hammers H, Srinivas S . Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma. N Engl J Med. 2015; 373(19):1803-13. PMC: 5719487. DOI: 10.1056/NEJMoa1510665. View

18.

Lohiya V, Aragon-Ching J, Sonpavde G . Role of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate Cancer. Clin Med Insights Oncol. 2016; 10(Suppl 1):57-66. PMC: 5065075. DOI: 10.4137/CMO.S34535. View

19.

Nielsen S, Schmid M . Macrophages as Key Drivers of Cancer Progression and Metastasis. Mediators Inflamm. 2017; 2017:9624760. PMC: 5292164. DOI: 10.1155/2017/9624760. View

20.

Studebaker A, Storci G, Werbeck J, Sansone P, Sasser A, Tavolari S . Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner. Cancer Res. 2008; 68(21):9087-95. DOI: 10.1158/0008-5472.CAN-08-0400. View